{"id":"NCT02854800","sponsor":"West Virginia University","briefTitle":"Smoking Cessation & Opioid Dependence Treatment Integration","officialTitle":"Smoking Cessation & Opioid Dependence Treatment Integration: Does Timing Matter?","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-07-08","primaryCompletion":"2017-04-10","completion":"2017-04-10","firstPosted":"2016-08-03","resultsPosted":"2020-08-05","lastUpdate":"2020-08-14"},"enrollment":74,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Smoking Cessation","Opioid Related Disorders"],"interventions":[{"type":"DRUG","name":"varenicline","otherNames":["Chantix"]}],"arms":[{"label":"Weekly Opioid Tx","type":"EXPERIMENTAL"},{"label":"Biweekly Opioid Tx","type":"EXPERIMENTAL"},{"label":"Monthly Opioid Tx","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study was to examine the feasibility of integrating a smoking cessation intervention for cigarette smokers enrolled in an outpatient program for opioid dependence. The secondary purpose was to compare treatment effects as a function of phase in the outpatient program: 0-90 days (weekly attendance), 90 days-1 year (biweekly attendance), and more than 1 year (monthly attendance).","primaryOutcome":{"measure":"Recruitment, Assignment to Treatment, and Retention Rates","timeFrame":"up to 12 weeks","effectByArm":[{"arm":"Weekly Opioid Tx","deltaMin":40,"sd":null},{"arm":"Bi-weekly Opioid Tx","deltaMin":33,"sd":null},{"arm":"Monthly Opioid Tx","deltaMin":15,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":[]}}